Article
Polymorphism of the TLR4 gene reduces the risk of hepatitis C virus-induced hepatocellular carcinoma.
Oncology - 1 Jan 2012
Agúndez José A, García-Martín Elena, Devesa María J, Carballo Miguel, Martínez Carmen, Lee-Brunner Anna, Fernández Cristina, Díaz-Rubio Manuel, Ladero José M
Abstract excerpt
OBJECTIVE: Toll-like receptor 4 (TLR4) signalling participates in the innate immune response against hepatitis C virus (HCV) infection. TLR4 gene polymorphisms may influence the risk of HCV-induced hepatocellular carcinoma (HCC). This is a single-centre-based study designed to analyse the distribution of several TLR4 gene single nucleotide polymorphisms in healthy controls and in patients chronically infected...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
